This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Cancer; other and unspecified primary
  • /
  • Management of refractory symptoms at the end of li...
Guideline

Management of refractory symptoms at the end of life and the use of palliative sedation

Read time: 1 mins
Last updated:4th Sep 2014

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
In patients with advanced cancer, a readiness to address pain and other intolerable symptoms is a medical and moral imperative [1]. This has been described by Roy as the ‘emancipation principle of palliative care’ which states: ‘(one should) spare no scientific or clinical effort to free dying persons from twisting and racking pain that invades, dominates, and shrivels their consciousness, that leaves them no psychic or mental space for the things they want to think and say, and do before they die.’ [2]. Indeed, there is a broad ethical consensus that, at the end of life, the provision of adequate relief of symptoms is an overriding goal, which must be pursued even in the setting of a narrow therapeutic index for the necessary palliative treatments [1, 3–12].

Read full guideline